Georgios Tsakonas

High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial

Bjørn Henning Grønberg, Kristin Toftaker Killingberg, Øystein Fløtten et al. · The Lancet Oncology · 2021 · 129 citations · Full text

Adaptive Radiotherapy, Oncology, Radiation Therapy +3

Effect of corticosteroids on the outcome of patients with advanced non–small cell lung cancer treated with immune-checkpoint inhibitors

Marcus Skribek, Konstantinos Rounis, Soren Afshar et al. · European Journal of Cancer · 2021 · 98 citations · Full text

Evaluation of the paclitaxel–ifosfamide–cisplatin (TIP) combination in relapsed and/or metastatic cervical cancer

Christos Kosmas, N. Mylonakis, Georgios Tsakonas et al. · British Journal of Cancer · 2009 · 36 citations · Full text

PTPN6 expression is epigenetically regulated and influences survival and response to chemotherapy in high-grade gliomas

Linda Sooman, Simon Ekman, Georgios Tsakonas et al. · Tumor Biology · 2014 · 30 citations

c-MET as a biomarker in patients with surgically resected non-small cell lung cancer

Georgios Tsakonas, Johan Botling, Patrick Micke et al. · Lung Cancer · 2019 · 29 citations

Prognostic Biomarkers, Surgical Oncology, Cancer Detection +7